Rutika Mehta, Hiroki Hara, Markus H. Moehler, Wenxi Tang, Kaijun Wang, Zhang Zhang, Viktor Chirikov, Wenying Quan, Lin Zhan. "Quality-adjusted survival comparison for tislelizumab (TIS) + chemotherapy (CT) versus placebo (PBO) + CT as first-line (1L) treatment in gastric/gastroesophageal junction adenocarcinoma (GC/GEJC) patients with peritoneal metastasis (PM): Long-term follow-up from RATIONALE-305.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.4034